109 related articles for article (PubMed ID: 27378570)
1. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
[TBL] [Abstract][Full Text] [Related]
2. Cardiac mGluR1 metabotropic receptors in cardioprotection.
Vincent A; Sportouch C; Covinhes A; Barrère C; Gallot L; Delgado-Betancourt V; Lattuca B; Solecki K; Boisguérin P; Piot C; Nargeot J; Barrère-Lemaire S
Cardiovasc Res; 2017 May; 113(6):644-655. PubMed ID: 28453728
[TBL] [Abstract][Full Text] [Related]
3. Liposomal tetrahydrobiopterin preserves eNOS coupling in the post-ischemic heart conferring in vivo cardioprotection.
Xie L; Talukder MA; Sun J; Varadharaj S; Zweier JL
J Mol Cell Cardiol; 2015 Sep; 86():14-22. PubMed ID: 26116866
[TBL] [Abstract][Full Text] [Related]
4. Netrin-1 improves post-injury cardiac function in vivo via DCC/NO-dependent preservation of mitochondrial integrity, while attenuating autophagy.
Bouhidel JO; Wang P; Siu KL; Li H; Youn JY; Cai H
Biochim Biophys Acta; 2015 Feb; 1852(2):277-89. PubMed ID: 24928309
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide inhibits endoplasmic reticulum stress through the GRP78/mTOR pathway in rat chondrocytes subjected to oxidative stress.
Wu J; Yang F; Zhang X; Chen G; Zou J; Yin L; Yang D
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33537813
[TBL] [Abstract][Full Text] [Related]
6. A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.
Huang C; Liu Y; Beenken A; Jiang L; Gao X; Huang Z; Hsu A; Gross GJ; Wang YG; Mohammadi M; Schultz JEJ
Cardiovasc Res; 2017 Nov; 113(13):1585-1602. PubMed ID: 29016740
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion.
Yin H; Chao L; Chao J
Life Sci; 2008 Jan; 82(3-4):156-65. PubMed ID: 18068196
[TBL] [Abstract][Full Text] [Related]
8. Using mechanism-based combinations of H
Ravani S; Chatzianastasiou A; Papapetropoulos A
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1853-1864. PubMed ID: 37773523
[TBL] [Abstract][Full Text] [Related]
9. The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway.
Do Carmo H; Arjun S; Petrucci O; Yellon DM; Davidson SM
Cardiovasc Drugs Ther; 2018 Apr; 32(2):165-168. PubMed ID: 29582211
[TBL] [Abstract][Full Text] [Related]
10. mTORC2 phosphorylation of Akt1: a possible mechanism for hydrogen sulfide-induced cardioprotection.
Zhou Y; Wang D; Gao X; Lew K; Richards AM; Wang P
PLoS One; 2014; 9(6):e99665. PubMed ID: 24949720
[TBL] [Abstract][Full Text] [Related]
11. Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury.
Yin X; Zheng Y; Zhai X; Zhao X; Cai L
Exp Diabetes Res; 2012; 2012():198048. PubMed ID: 21822424
[TBL] [Abstract][Full Text] [Related]
12. A slow-releasing donor of hydrogen sulfide inhibits neuronal cell death via anti-PANoptosis in rats with spinal cord ischemia‒reperfusion injury.
Xie L; Wu H; He Q; Shi W; Zhang J; Xiao X; Yu T
Cell Commun Signal; 2024 Jan; 22(1):33. PubMed ID: 38217003
[TBL] [Abstract][Full Text] [Related]
13. Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion.
Oyamada S; Bianchi C; Takai S; Chu LM; Sellke FW
J Pharmacol Exp Ther; 2011 Oct; 339(1):143-51. PubMed ID: 21795433
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine Protects Against Myocardial Ischemia-Reperfusion Injury Through Anti-ferroptosis in Type 1 Diabetic Mice.
Zhou D; Yang Y; Chen J; Zhou J; He J; Liu D; Zhang A; Yuan B; Jiang Y; Xia W; Han R; Xia Z
Cardiovasc Toxicol; 2024 May; 24(5):481-498. PubMed ID: 38647950
[TBL] [Abstract][Full Text] [Related]
15. A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury.
Sun X; Wang W; Dai J; Jin S; Huang J; Guo C; Wang C; Pang L; Wang Y
Sci Rep; 2017 Jun; 7(1):3541. PubMed ID: 28615705
[TBL] [Abstract][Full Text] [Related]
16. Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase/glycogen synthase kinase 3β/cyclin D1 signalling pathway.
Chen Z; Xie J; Hao H; Lin H; Wang L; Zhang Y; Chen L; Cao S; Huang X; Liao W; Bin J; Liao Y
Cardiovasc Res; 2017 May; 113(6):620-632. PubMed ID: 28453729
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen Sulfide Improves Outcomes in a Murine Model of Necrotizing Enterocolitis via the Cys440 Residue on Endothelial Nitric Oxide Synthase.
Hunter CE; Mesfin FM; Manohar K; Liu J; Shelley WC; Brokaw JP; Pecoraro AR; Hosfield BD; Markel TA
J Pediatr Surg; 2023 Dec; 58(12):2391-2398. PubMed ID: 37684170
[TBL] [Abstract][Full Text] [Related]
18. Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved.
Ragone MI; Bayley M; López S; Díaz RG; Consolini AE
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3093-3109. PubMed ID: 37878045
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic conditioning suppresses nitric oxide production upon myocardial reperfusion.
Ryou MG; Sun J; Oguayo KN; Manukhina EB; Downey HF; Mallet RT
Exp Biol Med (Maywood); 2008 Jun; 233(6):766-74. PubMed ID: 18408142
[TBL] [Abstract][Full Text] [Related]
20. C. elegans aging is modulated by hydrogen sulfide and the sulfhydrylase/cysteine synthase cysl-2.
Qabazard B; Ahmed S; Li L; Arlt VM; Moore PK; Stürzenbaum SR
PLoS One; 2013; 8(11):e80135. PubMed ID: 24260346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
